ArticleJSES reviews, reports, and techniques2026
Epigenetic alterations in rotator cuff tendinopathy and degenerative cuff tears: a systematic review.
Article in JSES reviews, reports, and techniques, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Recent advances in tendon redox biology: the interplay of oxidative stress, calcium signaling, and antioxidant defence mechanisms.Frontiers in pharmacology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Rotator cuff (RC) tendinopathy and degenerative cuff tears are common, disabling conditions with a complex molecular etiology. Furthermore, RC pathology becomes increasingly common with age, especially in the case of supraspinatus tendon injury. Concurrent with increased RC pathology during aging are epigenetic alterations, which makes the relationship between RC pathology and epigenetic alterations an area of interest. The role of epigenetics in RC pathology is still being elucidated but has potential to provide diagnostic biomarkers and therapeutic targets. We aimed to systematically review the altered epigenetic signatures and mechanisms underlying RC pathology. Methods: Four electronic databases (PubMed, Embase.com, Cochrane, and Google Scholar) were searched 27 August, 2024, for primary studies reporting on epigenetic alterations (DNA methylation, histone modifications, noncoding RNAs) in RC tendinopathy and associated atraumatic cuff tear tissue. Risk of bias and methodological quality of all included studies were assessed according to the Newcastle-Ottawa Scale. Results: Of the 1,190 identified references, 39 studies were included, totaling 464 human and 641 animal model participant shoulders. We identified altered expression of 87 microRNAs, 24 of which were reported on in multiple studies, 62 long noncoding RNAs, 26 circular RNAs, 9 histone modifications or histone-modifying enzymes, and 11 genes exhibiting altered DNA methylation within the disease state. Epigenetic signatures were most commonly associated with inflammation, extracellular matrix degeneration, muscle atrophy, and fatty infiltration. We also report on 15 studies characterizing epigenetic therapeutics (5 microRNA, 1 long noncoding RNA, 3 histone-modifying enzymes, and 6 gene silencing RNA). Conclusion: Our findings indicate that epigenetic regulation may play an important role in the pathophysiology of RC tendinopathy and degenerative tear and that there is a high potential for epigenetic biomarkers and therapeutics to aid in the diagnosis, prognosis, and treatment of this condition.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.